{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:33:31Z","timestamp":1792809211702,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-024-01637-3","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T09:43:10Z","timestamp":1732182190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huandong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"4","key":"1637_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.athoracsur.2023.06.004","volume":"116","author":"AL Potter","year":"2023","unstructured":"Potter AL, Costantino CL, Suliman RA, Haridas CS, Senthil P, Kumar A, et al. Recurrence after complete resection for non-small cell lung cancer in the national lung screening trial. Ann Thorac Surg. 2023;116(4):684\u201392.","journal-title":"Ann Thorac Surg"},{"issue":"13","key":"1637_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/1759-7714.15288","volume":"15","author":"Z Ma","year":"2024","unstructured":"Ma Z, Zhou Z, Wang S, Ji H, Zhao D, Wang L, et al. Clinical significance of postoperative folate receptor-positive circulating tumour cells (FR + CTCs) for long-term prognosis in patients with invasive adenocarcinoma (IAC) of the lung. Thoracic Cancer. 2024;15(13):1060\u201371.","journal-title":"Thoracic Cancer"},{"key":"1637_CR3","doi-asserted-by":"crossref","unstructured":"Garitaonaindia Y, Aguado-Noya R, Garcia-Grande A, Cordoba M, Albi MJC, Ca\u00f1averal JLC, et al. Monitoring with circulating tumour cells in the perioperative setting of patients with surgically treated stages I\u2013IIIA NSCLC. Transl Lung Cancer Res. 2023 Jul 31;12(7).","DOI":"10.21037\/tlcr-22-827"},{"key":"1637_CR4","doi-asserted-by":"crossref","unstructured":"Sawabata N, Nakamura T, Kawaguchi T, Watanabe T, Ouji NS, Ito T, et al. Circulating tumour cells detected only after surgery for non-small cell lung cancer: is it a predictor of recurrence? J Thoracic Dis. 2020 Sep;12(9).","DOI":"10.21037\/jtd-20-1636"},{"issue":"9","key":"1637_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41571-018-0058-3","volume":"15","author":"C Abbosh","year":"2018","unstructured":"Abbosh C, Birkbak NJ, Swanton C. Early stage NSCLC\u2014challenges to implementing ctDNA-based screening and MRD detection. Nat Rev Clin Oncol. 2018;15(9):577\u201386.","journal-title":"Nat Rev Clin Oncol"},{"key":"1637_CR6","first-page":"129","volume":"1","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhang X, Xie P, Zhang W. Liquid biopsy: an arsenal for tumour screening and early diagnosis. Cancer Treat Rev. 2024;1:129.","journal-title":"Cancer Treat Rev"},{"key":"1637_CR7","doi-asserted-by":"crossref","unstructured":"Zhang W, Duan X, Zhang Z, Yang Z, Zhao C, Liang C, et al. Combination of CT and telomerase+ circulating tumour cells improves diagnosis of small pulmonary nodules. JCI Insight. 2021 Jun 8;6(11).","DOI":"10.1172\/jci.insight.148182"},{"issue":"1","key":"1637_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12916-021-02138-7","volume":"19","author":"W Zhang","year":"2021","unstructured":"Zhang W, Qin T, Yang Z, Yin L, Zhao C, Feng L, et al. Telomerase-positive circulating tumour cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma. BMC Med. 2021;19(1):277.","journal-title":"BMC Med"},{"issue":"6","key":"1637_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/SLA.0000000000005708","volume":"277","author":"AA Javed","year":"2023","unstructured":"Javed AA, Ding D, Hasanain A, van Oosten F, Yu J, Cameron JL, et al. Persistent circulating tumour cells at 1 year after oncologic resection predict late recurrence in pancreatic cancer. Ann Surg. 2023;277(6):859.","journal-title":"Ann Surg"},{"issue":"7957","key":"1637_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-023-05776-4","volume":"616","author":"C Abbosh","year":"2023","unstructured":"Abbosh C, Frankell AM, Harrison T, Kisistok J, Garnett A, Johnson L, et al. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature. 2023;616(7957):553\u201362.","journal-title":"Nature"},{"issue":"1","key":"1637_CR11","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1038\/s41467-021-27022-z","volume":"12","author":"B Qiu","year":"2021","unstructured":"Qiu B, Guo W, Zhang F, Lv F, Ji Y, Peng Y, et al. Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC. Nat Commun. 2021;12(1):6770.","journal-title":"Nat Commun"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-024-01637-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-024-01637-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-024-01637-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T10:04:14Z","timestamp":1732183454000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-024-01637-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1637"],"URL":"https:\/\/doi.org\/10.1186\/s13045-024-01637-3","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with all relevant ethical regulations and was approved by the Ethics Committee of the National Cancer Center\/Cancer Hospital of Peking Union Medical College, Chinese Academy of Medical Sciences (No. 21\/093\u20132764). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all patients or their guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}